Nutraceuticals as potential therapeutic agents for preventing gastric cancer: towards targeting chronic inflammation

(1) Agudo A, Cayssials V, Bonet C, Tjønneland A, Overvad K, Boutron-Ruault M-C, et al. Inflammatory potential of the diet and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr. 2018;107(4):607-16, doi: 10.1093/ajcn/nqy002.

(2) Bockerstett KA, DiPaolo RJ. Regulation of Gastric Carcinogenesis by Inflammatory Cytokines. Cell Mol Gastroenterol Hepatol. 2017;4(1):47-53, doi: 10.1016/j.jcmgh.2017.03.005.

(3) Ekström AM, Held M, Hansson LE, Engstrand L, Nyrén O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology. 2001;121(4):784-91, doi: 10.1053/gast.2001.27999.

(4) Greten FR, Grivennikov SI. Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity. 2019;51(1):27-41, doi: 10.1016/j.immuni.2019.06.025.

(5) Al-Sammak F, Kalinski T, Weinert S, Link A, Wex T, Malfertheiner P. Gastric epithelial expression of IL-12 cytokine family in Helicobacter pylori infection in human: is it head or tail of the coin? PLoS One. 2013;8(9):e75192, doi: 10.1371/journal.pone.0075192.

(6) Kai H, Kitadai Y, Kodama M, Cho S, Kuroda T, Ito M, et al. Involvement of proinflammatory cytokines IL-1beta and IL-6 in progression of human gastric carcinoma. Anticancer Res. 2005;25(2A):709-13.

(7) Lang A, Lahav M, Sakhnini E, Barshack I, Fidder HH, Avidan B, et al. Allicin inhibits spontaneous and TNF-alpha induced secretion of proinflammatory cytokines and chemokines from intestinal epithelial cells. Clin Nutr. 2004;23(5):1199-208, doi: 10.1016/j.clnu.2004.03.011.

(8) Kowalski J, Samojedny A, Paul M, Pietsz G, Wilczok T. Effect of apigenin, kaempferol and resveratrol on the expression of interleukin-1beta and tumor necrosis factor-alpha genes in J774.2 macrophages. Pharmacol Rep. 2005;57(3):390-4.

(9) Bhutani M, Pathak AK, Nair AS, Kunnumakkara AB, Guha S, Sethi G, et al. Capsaicin is a novel blocker of constitutive and interleukin-6-inducible STAT3 activation. Clin Cancer Res. 2007;13(10):3024-32, doi: 10.1158/1078-0432.CCR-06-2575.

(10) Leyva-López N, Gutierrez-Grijalva EP, Ambriz-Perez DL, Heredia JB. Flavonoids as Cytokine Modulators: A Possible Therapy for Inflammation-Related Diseases. Int J Mol Sci. 2016;17(6):E921, doi: 10.3390/ijms17060921.

(11) Liu H-K, Wang Q, Li Y, Sun W-G, Liu J-R, Yang Y-M, et al. Inhibitory effects of gamma-tocotrienol on invasion and metastasis of human gastric adenocarcinoma SGC-7901 cells. J Nutr Biochem. 2010;21(3):206-13, doi: 10.1016/j.jnutbio.2008.11.004.

(12) Aggarwal BB, Sundaram C, Prasad S, Kannappan R. Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases. Biochem Pharmacol. 2010;80(11):1613-31, doi: 10.1016/j.bcp.2010.07.043.

(13) Kong P, Cai Q, Geng Q, Wang J, Lan Y, Zhan Y, et al. Vitamin intake reduce the risk of gastric cancer: meta-analysis and systematic review of randomized and observational studies. PLoS One. 2014;9(12):e116060, doi: 10.1371/journal.pone.0116060.

(14) Prakash D, Kumar N Cost Effective Natural Antioxidants. En: Gerald JK, Watson RR, Preedy VR, editores. Nutrients, Dietary Supplements, and Nutriceuticals: Cost Analysis Versus Clinical Benefits. Totowa, NJ: Humana Press; 2011. p. 163-87.